Dynamite News
हिन्दी Yuva

Drugs Controller General of India
Drugs Controller allows restricted emergency use of Covaxin for 6-12 years

DCGI (Drugs Controller General of India) gives restricted emergency use authorisation to BharatBiotech's Covaxin for children between the age of 6-12...
Bharat Biotech gets DCGI's nod to conduct intranasal booster dose trials

The Drugs Controller General of India (DCGI) on Friday granted permission to Bharat Biotech to conduct clinical trials of intranasal vaccine BBV154.
DGCI grants conditional market approval for Covaxin, Covishield

The Drugs Controller General of India (DCGI) on Thursday granted conditional regular market approval for COVID-19 vaccines Covaxin and Covishield for...
DCGI waiver likely to bring foreign vaccines like Pfizer, Moderna a step closer

The Drugs Controller General of India (DCGI) has done away with specific trials of COVID-19 vaccines that have been approved by other international re...
Zydus Cadila seeks DCGI approval for clinical trials for monoclonal antibodies cocktail to neutralis...

Zydus Cadila has sought approval from the Drugs Controller General of India (DCGI) to undertake clinical trials for monoclonal antibodies cocktail tha...
PM Modi congratulates nation, scientists after emergency use approval to COVID-19 vaccines

Prime Minister Narendra Modi congratulated the country as Drugs Controller General of India (DCGI) granted emergency use approval to Serum Institute o...
Serum Institute of India seeks emergency use authorisation for its COVID-19 vaccine 'Covishield'

The Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation for its COVID-19 va...








Your Opinion

Loading Poll …